ID19050A - Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya - Google Patents

Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya

Info

Publication number
ID19050A
ID19050A IDP971240A ID971240A ID19050A ID 19050 A ID19050 A ID 19050A ID P971240 A IDP971240 A ID P971240A ID 971240 A ID971240 A ID 971240A ID 19050 A ID19050 A ID 19050A
Authority
ID
Indonesia
Prior art keywords
carboxicate
drivings
manufacture
acid
new
Prior art date
Application number
IDP971240A
Other languages
English (en)
Inventor
Wilhelm Amberg
Andreas Kling
Dagmar Klinge
Hartmut Riechers
Ernst Baumann
Liliane Unger
Manfred Raschack
Stefan Hergenroder
Sabine Schult
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ID19050A publication Critical patent/ID19050A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
IDP971240A 1996-04-12 1997-04-14 Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya ID19050A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19614542A DE19614542A1 (de) 1996-04-12 1996-04-12 Neue Carbonsäurederivate, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ID19050A true ID19050A (id) 1998-06-04

Family

ID=7791123

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971240A ID19050A (id) 1996-04-12 1997-04-14 Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya

Country Status (23)

Country Link
US (1) US6103732A (id)
EP (1) EP0892788A1 (id)
JP (1) JP2000508325A (id)
KR (1) KR20000005366A (id)
CN (1) CN1216042A (id)
AR (1) AR006593A1 (id)
AU (1) AU711293B2 (id)
BG (1) BG63202B1 (id)
BR (1) BR9708614A (id)
CA (1) CA2250764A1 (id)
CO (1) CO4900038A1 (id)
DE (1) DE19614542A1 (id)
HR (1) HRP970200A2 (id)
ID (1) ID19050A (id)
IL (1) IL126026A0 (id)
NO (1) NO311802B1 (id)
NZ (1) NZ331704A (id)
PL (1) PL329240A1 (id)
SK (1) SK127698A3 (id)
TR (1) TR199802042T2 (id)
TW (1) TW419465B (id)
WO (1) WO1997038982A1 (id)
ZA (1) ZA973096B (id)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL334014A1 (en) * 1996-12-18 2000-01-31 Basf Ag Heterocyclic derivatives of carboxylic acids, their preduction and application as antagonists of endothelin receptors
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
KR20010023615A (ko) * 1997-09-04 2001-03-26 스타르크, 카르크 신규 카르복실산 유도체, 그 제조 및 혼합 ｅｔａ/ｅｔｂ엔도텔린 수용체 길항제로서의 용도
KR100523112B1 (ko) * 1997-10-17 2005-10-19 유로진 리미티드 레닌-안지오텐신계 억제제의 사용
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
DK1243262T3 (da) * 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter
ES2185606T3 (es) * 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
KR20070007931A (ko) 2004-04-16 2007-01-16 쉬바르츠파르마에이지 만성 두통의 예방 및 치료를 위한 펩티드 화합물의 용도
PL1781276T3 (pl) * 2004-08-27 2010-11-30 Ucb Pharma Gmbh Zastosowanie związków peptydowych do leczenia bólu związanego z rakiem kości, bólu indukowanego przez chemioterapię oraz nukleozydy
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
WO2007144195A2 (en) 2006-06-15 2007-12-21 Schwarz Pharma Ag Pharmaceutical composition with synergistic anticonvulsant effect

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411225A1 (de) * 1994-03-31 1995-10-05 Basf Ag Verwendung von Carbonsäurederivaten als Arzneimittel
WO1996000219A1 (en) * 1994-06-27 1996-01-04 Ciba-Geigy Ag Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides

Also Published As

Publication number Publication date
AU711293B2 (en) 1999-10-07
JP2000508325A (ja) 2000-07-04
AU2636497A (en) 1997-11-07
NZ331704A (en) 2000-06-23
AR006593A1 (es) 1999-09-08
NO984713L (no) 1998-10-09
BR9708614A (pt) 1999-08-03
TR199802042T2 (xx) 2000-09-21
HRP970200A2 (en) 1998-04-30
CA2250764A1 (en) 1997-10-23
WO1997038982A1 (de) 1997-10-23
CO4900038A1 (es) 2000-03-27
TW419465B (en) 2001-01-21
NO984713D0 (no) 1998-10-09
BG102770A (en) 1999-11-30
ZA973096B (en) 1998-10-12
US6103732A (en) 2000-08-15
BG63202B1 (bg) 2001-06-29
NO311802B1 (no) 2002-01-28
EP0892788A1 (de) 1999-01-27
PL329240A1 (en) 1999-03-15
CN1216042A (zh) 1999-05-05
IL126026A0 (en) 1999-05-09
SK127698A3 (en) 2000-03-13
DE19614542A1 (de) 1997-10-16
KR20000005366A (ko) 2000-01-25

Similar Documents

Publication Publication Date Title
ID17016A (id) Turunan-turunan asam yang baru dan penggunaannya sebagai penghambat-penghambat trombin
ID22490A (id) Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya
ID26305A (id) Benzamida tersubstitusi baru, pembuatan dan penggunaannya
ID21781A (id) Benzamidoaldehida baru dan penggunaannya
ID27757A (id) Indolinona-indolinona tersubstitusi baru, preparasi dan penggunaannya sebagai obat
ID18421A (id) Pembuatan asam akrilat dan asam metakrilat
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID26402A (id) Amida-amida tersubstitusi yang baru, pembuatan dan penggunaannya
ID25469A (id) Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya
ID16044A (id) Pemurnian asam akrilik dan asam metakrilik
DE69408679D1 (de) Herstellung von geformten faserstrukturen
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID16079A (id) Poliisosianat terblok baru dan penggunaanya
ID27126A (id) Proses pembuatan garam-garam asam karboksilat dan katalis-katalis yang berguna dalam proses tersebut
ID27558A (id) Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat
ID19050A (id) Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya
ID15914A (id) Pewarna-pewarna reaktif, pembuatan dan penggunaannya
ID16501A (id) Bentuk baru turunan asam alpha hidroksi pembuatan dan kegunaannya
ID22911A (id) Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya
ID16824A (id) Turunan-turunan asam karboksilat yang baru, pembuatan dan penggunaannya
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
ID18425A (id) Pembuatan asam akrilat dan asam metakrilat
ID23990A (id) Komposisi-komposisi pencuci asam yang mengandung amina-amina teralkoksilat dan penggunannya
ID22688A (id) Polimerisasi yang dikatalisa oleh asam dan diperbaiki
ID24283A (id) Turunan-turunan asam karboksilat baru, pembuatannya dan penggunaannya dalam pengobatan kanker